Active Research Protocols
- 02-AR-0156 – A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab in Patients with Dermatomyositis and Polymyositis
- 07-E-0012 – Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
- 13-E-0015 – Environmental Risk Factors for the Development of Myositis in Military Personnel
- 91-AR-0196 – Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases
- 94-E-0165 – Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014